Hepatocellular carcinoma with hepatic vein invasion should not be considered a contraindication for liver resection
Xiu‐Ping Zhang, Kang Wang, Zhen‐Hua Chen, Shu‐Qun Cheng – 20 November 2017
Issue Information
20 November 2017
Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV‐1 study
Cihan Yurdaydin, Onur Keskin, Çağdaş Kalkan, Fatih Karakaya, Aysun Çalişkan, Ersin Karatayli, Senem Karatayli, A. Mithat Bozdayi, Christopher Koh, Theo Heller, Ramazan Idilman, Jeffrey S. Glenn – 20 November 2017 – In a proof‐of‐concept (POC) study, the oral prenylation inhibitor, lonafarnib (LNF), decreased hepatitis D virus (HDV) RNA during 4 weeks of treatment. Here, we explored optimal LNF regimens.
The role of genetics in hepatic fibrosis among hepatitis C virus patients
Heiyoung Park, Thomas R. O’Brien, Barbara Rehermann – 20 November 2017
Longterm calcineurin inhibitor therapy and brain function in patients after liver transplantation
Henning Pflugrad, Anna‐Kristina Schrader, Anita Blanka Tryc, Xiaoqi Ding, Heinrich Lanfermann, Elmar Jäckel, Harald Schrem, Jan Beneke, Hannelore Barg‐Hock, Jürgen Klempnauer, Karin Weissenborn – 20 November 2017 – Calcineurin inhibitors (CNIs) frequently induce neurological complications early after orthotopic liver transplantation (OLT). We hypothesize that longterm CNI therapy after OLT causes dose‐dependent cognitive dysfunction and alteration of brain structure.
Table of contents
20 November 2017
Notices
20 November 2017
Instructions to authors and Information for readers
20 November 2017
Memory T cells are significantly increased in rejected liver allografts of rhesus monkeys
Hwajung Kim, Hyeyoung Kim, Sun‐Kyung Lee, Xue‐Li Jin, Tae Jin Kim, Chanho Park, Jae‐Il Lee, Hyo‐Sin Kim, Suk Kyun Hong, Kyung Chul Yoon, Sung Woo Ahn, Kyoung‐Bun Lee, Nam‐Joon Yi, Jaeseok Yang, Kwang‐Woong Lee, Wayne J. Hawthorne, Kyung‐Suk Suh – 18 November 2017 – The rhesus monkey (RM) is an excellent preclinical model in kidney, heart, and islet transplantation that has provided the basis for new immunosuppressive protocols for clinical studies. However, there remain relatively few liver transplantation (LT) models in nonhuman primates.